Application | Comment | Organism |
---|---|---|
medicine | kinetics of prostate-specific antigen are indicative of tumour progression and are therefore used in clinical decision-making in men on active surveillance for early prostate cancer. A high prostate-specific antigen velocity or short prostate-specific antigen doubling time are related with an unfavourable outcome and should lead to performing an additional prostate biopsy or to deferred radical treatment during follow-up of active surveillance. A low prostate-specific antigen velocity or a long prostate-specific antigen doubling time is associated with a nonaggressive course of the disease and may justify a more conservative attitude. A prostate-specific antigen doubling time more than 10 years, a static course of the prostate-specific antigen values, or a negative prostate-specific antigen doubling time are generally associated with a good prognosis. A prostate-specific antigen doubling time of less than 3-4 years should lead to the advice to switch to radical treatment | Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
serum | - |
Homo sapiens | - |
Synonyms | Comment | Organism |
---|---|---|
prostate-specific antigen | - |
Homo sapiens |
PSA | - |
Homo sapiens |